Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

IBB vs VCSH: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, IBB returned +37.5% to VCSH's +1.3%, and VCSH charges 0.03% to IBB's 0.44%.

askIQ about this page

askIQ about IBB and VCSH

Net assets: $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF, and $43.9bn on Sep 30, 2026 for Vanguard Short-Term Corporate Bond ETF.

At a glance
+37.5%
IBB total return, 1 year
+1.3%
VCSH total return, 1 year
0.44%
IBB expense ratio
0.03%
VCSH expense ratio

Pair scorecard

VCSH costs 0.41 points a year less; their one-year returns differ by 36.2 points; VCSH is 3.9 times larger.

IBB vs VCSH: Differences, Returns & Fees
MeasureIBBVCSH
Return
Total return, 1 year+37.5%+1.3%
Benchmark
What it tracksBiotechBloomberg U.S. 1-5 Year Corporate Bond Index
Cost and size
Expense ratio0.44%0.03%
Net assets, as of Sep 30, 2026$11.2bn$43.9bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
In the S&P 500, by weight40%
Top ten holdings, share of the fund50%

Holdings in common uses holdings dated Sep 30, 2026 and Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, IBB and VCSH hold 0% of their money in the same securities at the same weight. Holdings dated Sep 30, 2026 and Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first IBB VCSH
Only in one fund ↓
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Only in VCSH
MKTLIQ 0.68%
Bank of America Corp 0.23%
Space Exploration Technologies Corp 0.22%
CVS Health Corp 0.20%
AbbVie Inc 0.20%
Amazon.com Inc 0.19%
Boeing Co 0.19%
T-Mobile USA Inc 0.19%
Check overlap with more funds →

Side by side

IBB iShares Biotechnology ETF VCSH Vanguard Short-Term Corporate Bond ETF
Where it sits Thematic ETF Bond ETF
What it is Biotech Tracks an index of Short-Term Corporate Bond
Total return, 1 year +37.5% +1.3%
Its benchmark over the same days not measured +1.3% (SCHJ)
Gap to its benchmark not measured 0.0 pts vs SCHJ
Expense ratio 0.44% 0.03%
Holdings 245 3064
Net assets, IBB as of Oct 27, 2026 and VCSH as of Sep 30, 2026 $11.0bn $43.9bn

IBB and VCSH on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

IBB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

VCSH

VCSH tracks an index of Short-Term Corporate Bond. Over the year to Oct 28, 2026 it returned +1.3% with distributions reinvested, against +1.3% for its benchmark, the Bloomberg U.S. 1-5 Year Corporate Bond Index. The prospectus expense ratio is 0.03% a year.

Questions people ask

Are IBB and VCSH in the same category?
IBB is a thematic ETF and VCSH is a bond ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, IBB or VCSH?
In the year to Oct 28, 2026, with distributions reinvested, IBB returned +37.5% and VCSH +1.3%.
Which is cheaper, IBB or VCSH?
VCSH is cheaper, by 0.41 percentage points a year. That is about $41 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, IBB against VCSH, data as of Oct 28, 2026. https://etfiq.com/compare/any/ibb-vs-vcsh

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.